SEC Form 4 · accession 0001209191-15-022537
HERON THERAPEUTICS, INC. /DE/ · HRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barry D Quart
Officer — Chief Executive Officer · Director
Period of report
Mar 2, 2015
Accepted (ET)
Mar 4, 2015 · 6:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000818033
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Mar 2, 2015 | S | 10,000 | $13.0727 | D | 42,868 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of December 23, 2014.
- F2The range of sales prices received was $12.94 to $13.43. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.